Global Cardiac Assist Devices (CAD) Market - Forecasts to 2024

  • ID: 4455948
  • Report
  • Region: Global
  • 371 Pages
  • IQ4I Research & Consultancy Pvt. Ltd
1 of 6
Cardiac Assist Devices Global Market is Expected to Grow at a Double Digit CAGR to Reach $4,255.5 Million by 2024

FEATURED COMPANIES

  • Abbott Laboratories
  • Berlin Heart GmbH
  • Carmat SA
  • Evaheart, Inc.
  • Medtronic Plc
  • Procyrion
  • MORE

According to analysis, cardiac assist devices global market is expected to grow at a double digit CAGR to reach $4,255.5 million by 2024. Products of Cardiac assist devices market is segmented into Ventricular Assist Device {(Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD) and Biventricular Assist Devices (Bi-VAD)}, Total Artificial Heart (TAH) and Intra-Aortic Balloon Pump (IABP). CAD market by pump type is segmented into Pulsating or Pneumatic Pump and Continuous Flow Pump. The continuous flow pump is further segmented into Axial flow pump and Centrifugal flow pump. CAD market by implant type is segmented into Extracorporeal CAD, Intracorporeal CAD and Percutaneous CAD. CAD market by patient type is segmented into Adult and Pediatric CAD. Applications of Cardiac assist devices are segmented into Bridge to Transplant (BTT), Bridge to destination (BTD), Bridge to Recovery (BTR). End-User of Cardiac assist devices are segmented into hospitals, academics & research institutes and other End-user (catheterization labs and ambulatory settings).

This report concentrates on Cardiac assist devices that are placed internally (VAD, TAH), externally (VAD) and percutaneously (VAD and IABP) for treating end-stage heart failure, cardiogenic shock, ventricular insufficiency, acute heart attack, intraoperative and postoperative cardiac procedures. The mechanical circulatory devices like extracorporeal membrane oxygenation (ECMO) or Heart lung machine and other cardiac assist devices like pacemakers and defibrillators are not considered in Cardiac assist devices global market report.

Some of the key players of the Cardiac assist devices are Abbott Laboratories (U.S.), Medtronic PLC (Ireland), Abiomed (U.S.), Reliant Heart (U.S.), Fresenius Medical Care AG & Co. KGaA Care AG & Co. KGaA (Germany), Getinge Group (Sweden), Syncardia Systems, Inc (U.S.), Zeon Corporation (Japan), Teleflex Incorporated (U.S.), etc.

READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Berlin Heart GmbH
  • Carmat SA
  • Evaheart, Inc.
  • Medtronic Plc
  • Procyrion
  • MORE

1 Executive Summary

2 Introduction
2.1 Key Takeaways
2.2 Report Description
2.3 Markets Covered
2.4 Stakeholders
2.5 Research Methodology
2.5.1 Market Size Estimation
2.5.2 Market Breakdown and Data Triangulation
2.5.3 Secondary Sources
2.5.4 Primary Sources
2.5.5 Key Data Points from Secondary Sources
2.5.6 Key Data Points from Primary Sources
2.5.7 Assumptions

3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers and Opportunities
3.3.1.1 Increasing Incidence of Heart Failure
3.3.1.2 Shortage of Heart Donors
3.3.1.3 Technological Advancements in VAD
3.3.1.4 Rising Geriatric Population
3.3.1.5 Vast Pipeline Products
3.3.1.6 Increase in Funding for CAD Research
3.3.2 Restraints and Threats
3.3.2.1 Adverse Events and Complication With the Implantations of CAD
3.3.2.2 Cost of the Devices
3.3.2.3 Lack of Skilled and Trained Professionals
3.3.2.4 Stringent Regulatory Guidelines
3.3.2.5 Availability of Alternative Products
3.3.2.6 Cardiac Assist Devices Product Recalls Due to FDA Mandates
3.4 Regulatory Affairs
3.4.1 International Organization for Standardization
3.4.2 U.S.
3.4.3 Canada
3.4.4 Europe
3.4.5 China
3.4.6 Japan
3.4.7 India
3.5 Reimbursement Scenario
3.5.1 Reimbursement Table
3.5.1.1 Ventricular Assist Device Reimbursement
3.5.1.2 CAD Physician Reimbursement
3.6 Upcoming Technology
3.7 Clinicl Trial Data
3.8 Patent Trends
3.9 Technological Advancements
3.9.1 Introduction
3.9.2 Percutaneous Ventricular Assist Devices (PVAD)
3.9.3 Medical Coatings for Cardiac Assist Devices
3.9.4 Advancement in Blood Flow Technology
3.10 Porter’s Five Force Analysis
3.10.1 Threat of New Entrants
3.10.2 Threat of Substitutes
3.10.3 Bargaining Power of Suppliers
3.10.4 Bargaining Power of Buyers
3.10.5 Competitive Rivalry
3.11 Supply Chain Analysis
3.12 Market Share Analysis by Major Players
3.12.1 Cardiac Assist Device Global Market Share Analysis
3.12.2 Ventricular Assist Device Global Market Share Analysis
3.12.3 Intra-Aortic Balloon Pump Global Market Share Analysis
3.13 Cardiac Assist Devices Number of Units by Region
3.13.1 Ventricular Assist Devices Number of Units by Region
3.13.1.1 Extracorporeal Ventricular Assist Devices
3.13.1.2 Intracorporeal Ventricular Assist Devices
3.13.1.3 Percutaneous Ventricular Assist Devices
3.13.2 Total Artificial Heart Number of Units by Region
3.14 Comparison of Cardiac Assist Devices

4 Cardiac Assist Devices Global Market, by Product
4.1 Introduction
4.2 Ventricular Assist Devices (VAD)
4.2.1 Left Ventricular Assist Devices (LVAD)
4.2.2 Right Ventricular Assist Devices (RVAD)
4.2.3 Bi-Ventricular Assist Devices (BiVAD)
4.3 Intra-Aortic Balloon Pumps (IABP)
4.4 Total Artficial Heart (TAH)

5 Cardiac Assist Devices Global Market, by Implant Type
5.1 Introduction
5.2 Extracorporeal or Paracorporeal CAD
5.3 Intracorporeal CAD
5.4 Percutaneous CAD

6 Cardiac Assist Devices Global Market, by Pump Type
6.1 Introduction
6.2 Pulsatile Flow Pump
6.3 Continuous Flow Pump
6.3.1 Centrifugal Flow Pump
6.3.2 Axial Flow Pump

7 Cardiac Assist Devices Global Market, by Patient Type
7.1 Introduction
7.2 Pediatric CAD
7.3 Adult CAD

8 Cardiac Assist Devices Global Market, by Application
8.1 Introduction
8.2 Bridge to Transplant (BTT)
8.3 Bridge to Destination Therapy (BTD)
8.4 Bridge to Recovery (BTR)

9 Cardiac Assist Devices Global Market, by End-Users
9.1 Introduction
9.2 Hospitals
9.3 Academics & Research Institutes
9.4 Other End-Users

10 Regional Analysis
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Others
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K.
10.3.4 Others
10.4 Apac
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Others
10.5 Row
10.5.1 Brazil
10.5.2 Rest of Latin America
10.5.3 Middle East and Others

11 Company Developments
11.1 Introduction
11.2 Approvals
11.3 Acquisitions
11.4 Partnerships
11.5 Other Developments

12 Major Companies
12.1 Abbott Laboratories
12.1.1 Overview
12.1.2 Financials
12.1.3 Product Portfolio
12.1.4 Key Developments
12.1.5 Business Strategy
12.1.6 SWOT Analysis
12.2 Abiomed, Inc.
12.2.1 Overview
12.2.2 Financials
12.2.3 Product Portfolio
12.2.4 Key Developments
12.2.5 Business Strategy
12.2.6 SWOT Analysis
12.3 Berlin Heart GmbH
12.3.1 Overview
12.3.2 Financials
12.3.3 Product Portfolio
12.3.4 Key Developments
12.3.5 Business Strategy
12.3.6 SWOT Analysis
12.4 Bivacor Inc.
12.4.1 Overview
12.4.2 Financials
12.4.3 Product Portfolio
12.4.4 Key Developmnts
12.4.5 Business Strategy
12.4.6 SWOT Analysis
12.5 Carmat SA
12.5.1 Overview
12.5.2 Financials
12.5.3 Product Portfolio
12.5.4 Key Developmnts
12.5.5 Business Strategy
12.5.6 SWOT Analysis
12.6 Fresenius Medical Care AG & Co. KGaA (Xenios AG)
12.6.1 Overview
12.6.2 Financials
12.6.3 Product Portfolio
12.6.4 Key Developmnts
12.6.5 Business Strategy
12.6.6 SWOT Analysis
12.7 Getinge Group (Maquet)
12.7.1 Overview
12.7.2 Financials
12.7.3 Product Portfolio
12.7.4 Key Developments
12.7.5 Business Strategy
12.7.6 SWOT Analysis
12.8 Medtronic, Plc
12.8.1 Overview
12.8.2 Financials
12.8.3 Product Portfolio
12.8.4 Key Developments
12.8.5 Business Strategy
12.8.6 SWOT Analysis
12.9 Reliantheart Inc.
12.9.1 Overview
12.9.2 Financials
12.9.3 Product Portfolio
12.9.4 Key Developmnts
12.9.5 Business Strategy
12.9.6 SWOT Analysis
12.10 Syncardia Systems, Inc
12.10.1 Overview
12.10.2 Financials
12.10.3 Product Portfolio
12.10.4 Key Developments
12.10.5 Business Strategy
12.10.6 SWOT Analysis
12.11 Teleflex Incorporated
12.11.1 Overview
12.11.2 Financials
12.11.3 Product Portfolio
12.11.4 Key Developments
12.11.5 Business Strategy
12.11.6 SWOT Analysis
12.12 Zeon Corporation
12.12.1 Overview
12.12.2 Financials
12.12.3 Product Portfolio
12.12.4 Key Developments
12.12.5 Business Strategy
12.12.6 SWOT Analysis

List of Tables
Table 1 Cardiac Assist Devices Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 2 Extracorporeal Vad Number of Units, by Region, (2016-2024) (No’S)
Table 3 Intracorporeal Vad Number of Units, by Region, (2016-2024) (No’S)
Table 4 Percutaneous Vad Number of Units, by Region, (2016-2024) (No’S)
Table 5 Total Artificial Heart Number of Units, by Region, (2016-2024) (No’S)
Table 6 Cardiac Assist Devices Global Market Revenue, by Products, (2016-2024) ($Mn)
Table 7 Ventricular Assist Devices Global Market Revenue, by Products, (2016-2024) ($Mn)
Table 8 Ventricular Assist Devices Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 9 Left Ventricular Assist Devices Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 10 Right Ventricular Assist Devices Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 11 Bi-Ventricular Assist Devices Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 12 Intra-Aortic Balloon Pump Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 13 Total Artificial Heart Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 14 Cardiac Assist Devices Global Market Revenue, by Implant Type, (2016-2024) ($Mn)
Table 15 Extracorporeal or Paracorporeal CAD Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 16 Intracorporeal CAD Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 17 Percutaneous CAD Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 18 Cardiac Assist Devices Global Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 19 Pulsatile Flow Pump Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 20 Continuous Flow Pump Global Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 21 Continuous Flow Pump Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 22 Centrifugal Flow Pump Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 23 Axial Flow Pump Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 24 Cardiac Assist Devices Global Market Revenue, by Patient Type, (2016-2024) ($Mn)
Table 25 Pediatric CAD Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 26 Adult CAD Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 27 Cardiac Assist Device Global Market Revenue, by Application, (2016-2024) ($Mn)
Table 28 Bridge to Transplant Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 29 Bridge to Destination Therapy Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 30 Bridge to Recovery Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 31 Cardiac Assist Device Global Market Revenue, by End-Users, (2016-2024) ($Mn)
Table 32 Hospital Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 33 Academics & Research Institutes Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 34 Other End-User Global Market Revenue, by Region, (2016-2024) ($Mn)
Table 35 Cardiac Assist Device Global Market Revenue, by Region, (2016-2024) ($Mn), Cagr (%)
Table 36 North America Cardiac Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 37 North America Ventricular Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 38 North America Cardiac Assist Devices Market Revenue, by Implant Type, (2016-2024) ($Mn)
Table 39 North America Cardiac Assist Devices Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 40 North America Continuous Flow Pump Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 41 North America Cardiac Assist Devices Market Revenue, by Patient Type, (2016-2024) ($Mn)
Table 42 North America Cardiac Assist Devices Market Revenue, by Application, (2016-2024) ($Mn)
Table 43 North America Cardiac Assist Devices Market Revenue, by End-User, (2016-2024) ($Mn)
Table 44 North America Cardiac Assist Devices Market Revenue, by Country, (2016-2024) ($Mn)
Table 45 Europe Cardiac Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 46 Europe Ventricular Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 47 Europe Cardiac Assist Devices Market Revenue, by Implant Type, (2016-2024) ($Mn)
Table 48 Europe Cardiac Assist Devices Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 49 Europe Continuous Flow Pump Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 50 Europe Cardiac Assist Devices Market Revenue, by Patient Type, (2016-2024) ($Mn)
Table 51 Europe Cardiac Assist Devices Market Revenue, by Application, (2016-2024) ($Mn)
Table 52 Europe Cardiac Assist Devices Market Revenue, by End-User, (2016-2024) ($Mn)
Table 53 Europe Cardiac Assist Devices Market Revenue, by Country, (2016-2024) ($Mn)
Table 54 APAC Cardiac Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 55 APAC Ventricular Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 56 APAC Cardiac Assist Devices Market Revenue, by Implant Type, (2016-2024) ($Mn)
Table 57 APAC Cardiac Assist Devices Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 58 APAC Continuous Flow Pump Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 59 APAC Cardiac Assist Devices Market Revenue, by Patient Type, (2016-2024) ($Mn)
Table 60 APAC Cardiac Assist Devices Market Revenue, by Application, (2016-2024) ($Mn)
Table 61 APAC Cardiac Assist Devices Market Revenue, by End-User, (2016-2024) ($Mn)
Table 62 APAC Cardiac Assist Devices Market Revenue, by Country, (2016-2024) ($Mn)
Table 63 Row Cardiac Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 64 Row Ventricular Assist Devices Market Revenue, by Product, (2016-2024) ($Mn)
Table 65 Row Cardiac Assist Devices Market Revenue, by Implant Type, (2016-2024) ($Mn)
Table 66 Row Cardiac Assist Devices Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 67 Row Continuous Flow Pump Market Revenue, by Pump Type, (2016-2024) ($Mn)
Table 68 Row Cardiac Assist Devices Market Revenue, by Patient Type, (2016-2024) ($Mn)
Table 69 Row Cardiac Assist Devices Market Revenue, by Application, (2016-2024) ($Mn)
Table 70 Row Cardiac Assist Devices Market Revenue, by End-User, (2016-2024) ($Mn)
Table 71 Row Cardiac Assist Devices Market Revenue, by Country, (2016-2024) ($Mn)
Table 72 Approvals, (2015-2017)
Table 73 Acquisitions (2015-2017)
Table 74 Partnerships (2015-2017)
Table 75 Other Developments (2015-2017)
Table 76 Abbott Laboratories: Total Revenue and R&D Expenses, (2015-2017) ($Mn)
Table 77 Abbott Laboratories: Total Revenue by Segments, (2015-2017) ($Mn)
Table 78 Abbott Laboratories: Total Revenue by Geography, (2015-2017) ($Mn)
Table 79 Abiomed: Total Revenue and R&D Expenses, (2015-2017) ($Mn)
Table 80 Abiomed: Total Revenue, by Segments, (2015-2017) ($Mn)
Table 81 Fresenius Medical Care Ag & Co. KGaA: Total Revenue and R&D Expenses, (2015-2017) ($Mn)
Table 82 Fresenius Medical Care Ag & Co. KGaA: Total Revenue, by Segments, (2015-2017) ($Mn)
Table 83 Fresenius Medical Care Ag & Co. KGaA: Total Revenue, by Geography (2015-2017) ($Mn)
Table 84 Getinge Groups: Total Revenue and R&D Expenses, (2015-2017) ($Mn)
Table 85 Getinge Groups: Total Revenue, by Segment, (2015-2017) ($Mn)
Table 86 Getinge Groups: Total Revenue, by Geography, (2015-2017) ($Mn)
Table 87 Medtronic, Plc: Total Revenue and R&D Expenses, (2015-2017) ($Mn)
Table 88 Medtronic, Plc: Total Revenue, by Segments, (2015-2017) ($Mn)
Table 89 Medtronic, Plc: Cardiac & Vascular Total Revenue, by Sub-Segments, (2015-2017) ($Mn)
Table 90 Medtronic, Plc: Total Revenue, by Geography, (2015-2017) ($Mn)
Table 91 Teleflex Incorporated: Total Sales and R&D Expenses, (2015-2017) ($Mn)
Table 92 Teleflex Incorporated: Total Sales, by Segments, (2015-2017) ($Mn)
Table 93 Teleflex Incorporated: Total Sales, by Geography, (2015-2017) ($Mn)
Table 94 Zeon Corporation: Total Revenue and R&D Expenses, (2015-2017) ($Mn)
Table 95 Zeon Corporation: Total Revenue, by Segments, (2015-2017) ($Mn)
Table 96 Zeon Corporation: Total Revenue, by Geography, (2015-2017) ($Mn)

List of Figures
Figure 1 Cardiac Assist Devices Global Market Revenue, by Region (2016-2024) ($Mn)
Figure 2 Research Methodology: Cardiac Assist Devices Global Market
Figure 3 Cardiac Assist Devices Global Market: Top-Down and Bottom-Up Approach
Figure 4 Cardiac Assist Devices Global Market: Forecasting Model
Figure 5 Cardiac Assist Devices Global Market: Market Breakdown & Data Triangulation
Figure 6 Cardiac Assist Devices Global Market Segmentation
Figure 7 Market Dynamics
Figure 8 Cardiac Assist Devices Market: Patent Filing by Major Players (2012-2017)
Figure 9 Cardiac Assist Device Global Market: Porter’S Analysis
Figure 10 Cardiac Assist Device Global Market: Supply Chain Analysis
Figure 11 Cardiac Assist Device Global Market Share Analysis, by Key Players, 2017 (%)
Figure 12 Ventricular Assist Device Global Market Share Analysis, by Key Players, 2017 (%)
Figure 13 Intra-Aortic Balloon Pump Global Market Share Analysis, by Key Players, 2017 (%)
Figure 14 Extracorporeal Ventricular Assist Device Number of Units, by Region (2017 V/S 2024) (No’S)
Figure 15 Intracorporeal Ventricular Assist Devices Number of Units, by Region (2017 V/S 2024) (No’S)
Figure 16 Percutaneous Ventricular Assist Devices Number of Units, by Region (2017 V/S 2024) (No’S)
Figure 17 Total Artificial Heart Number of Units, by Region (2017 V/S 2024) (No’S)
Figure 18 Cardiac Assist Devices Global Market Revenue, by Products (2017 V/S 2024) ($Mn)
Figure 19 Ventricular Assist Devices Global Market Revenue, by Products (2017 V/S 2024) ($Mn)
Figure 20 Ventricular Assist Devices Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 21 Left Ventricular Assist Devices Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 22 Right Ventricualr Assist Devices Global Market Share, by Region (2017 V/S 2024) (%)
Figure 23 Bi-Ventricular Assist Devices Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 24 Intra-Aortic Balloon Pump Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 25 Total Artificial Heart Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 26 Cardiac Assist Devices Global Market Revenue, by Implant Type (2017 V/S 2024) ($Mn)
Figure 27 Extracorporeal CAD Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 28 Intracorporeal CAD Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 29 Percutaneous CAD Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 30 Cardiac Assist Devices Global Market Revenue, by Pump Type (2017 V/S 2024) ($Mn)
Figure 31 Pulsatile Flow Pump Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 32 Continuous Flow Pump Global Market Revenue, by Pump Type (2017 V/S 2024) ($Mn)
Figure 33 Continuous Flow Pump Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 34 Centrifugal Flow Pump Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 35 Axial Flow Pump Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 36 Cardiac Assist Devices Global Market Revenue, by Patient Type (2017 V/S 2024) ($Mn)
Figure 37 Pediatric CAD Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 38 Adult Vad Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 39 Cardiac Assist Device Global Market Revenue, by Application, (2017 V/S 2024) ($Mn)
Figure 40 Bridge to Transplant Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 41 Bridge to Destination Therapy Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 42 Bridge to Recovery Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 43 Cardiac Assist Device Global Market Revenue, by End-User, (2017 V/S 2024) ($Mn)
Figure 44 Hospital Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 45 Academic & Research Institutes Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 46 Other End-User Global Market Share, by Region, (2017 V/S 2024) (%)
Figure 47 Cardiac Assist Device Global Market Revenue, by Region (2016-2024) ($Mn), Cagr (%)
Figure 48 North America Cardiac Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 49 North America Ventricular Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 50 North America Cardiac Assist Devices Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 51 North America Cardiac Assist Devices Market Revenue, by End-User, (2017 V/S 2024) ($Mn)
Figure 52 North America Cardiac Assist Devices Market Revenue, by Country, (2017 V/S 2024) ($Mn)
Figure 53 U.S. Cardiac Assist Devices Market Revenue, by Products/Application (2017 V/S 2024) ($Mn)
Figure 54 U.S. Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 55 Others Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 56 Others Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 57 Europe Cardiac Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 58 Europe Ventricular Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 59 Europe Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 60 Europe Cardiac Assist Devices Market Revenue, by End-User, (2017 V/S 2024) ($Mn)
Figure 61 Europe Cardiac Assist Devices Market Revenue, by Country, (2017 V/S 2024) ($Mn)
Figure 62 Germany Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 63 Germany Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 64 France Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 65 France Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 66 U.K. Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 67 U.K. Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 68 Others Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 69 Others Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 70 APAC Cardiac Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 71 APAC Ventricular Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 72 APAC Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 73 APAC Cardiac Assist Devices Market Revenue, by End-User, (2017 V/S 2024) ($Mn)
Figure 74 APAC Cardiac Assist Devices Market Revenue, by Country, (2017 V/S 2024) ($Mn)
Figure 75 Japan Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 76 Japan Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 77 China Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 78 China Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 79 India Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 80 India Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 81 Others Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 82 Others Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 83 Row Cardiac Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 84 Row Ventricular Assist Devices Market Revenue, by Products, (2017 V/S 2024) ($Mn)
Figure 85 Row Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 86 Row Cardiac Assist Devices Market Revenue, by End-User, (2017 V/S 2024) ($Mn)
Figure 87 Row Cardiac Assist Devices Market Revenue, by Country, (2017 V/S 2024) ($Mn)
Figure 88 Brazil Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 89 Brazil Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 90 Rest of Latin America Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 91 Rest of Latin America Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 92 Middle East and Others Cardiac Assist Devices Market Revenue, by Product/Application (2017 V/S 2024) ($Mn)
Figure 93 Middle East and Others Cardiac Assist Devices Market Revenue, by Implant Type/Pump Type/Patient Type/End-User (2017 V/S 2024) ($Mn)
Figure 94 Key Growth Strategies, (2015-2017)
Figure 95 Approvals by Major Companies (2017-2024)
Figure 96 Acquisition by Major Companies (2017-2024)
Figure 97 Other Developments by Major Companies (2017-2024)
Figure 98 SWOT: Abbott Laboratories
Figure 99 SWOT: Abiomed
Figure 100 SWOT: Berlin Heart GmbH
Figure 101 SWOT: Bivacor Inc.
Figure 102 SWOT: Carmat Sa
Figure 103 SWOT: Fresenius Medical Care Ag & Co. KGaA Care (Xenios AG)
Figure 104 SWOT: Getinge Group (Maquet)
Figure 105 SWOT: Medtronic, Plc
Figure 106 SWOT: Reliantheart, Inc.
Figure 107 SWOT: Syncardia Systems, Inc
Figure 108 SWOT: Teleflex Incorporated
Figure 109 SWOT: Zeon Corporation

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6

FEATURED COMPANIES

  • Abbott Laboratories
  • Berlin Heart GmbH
  • Carmat SA
  • Evaheart, Inc.
  • Medtronic Plc
  • Procyrion
  • MORE

The heart conditions are considered advanced or end stage heart failure, when conventional heart therapies and management strategies no longer work. The reduced ability of the heart to pump blood and maintain normal bodily function leads to heart failure. Heart transplantation is currently the preferred treatment for end-stage heart failure. The availability of donor hearts is insufficient to meet the required demand and many patients are not eligible for transplantation due to age and other health conditions.

The Cardiac assist devices (CAD) i.e. VAD, TAH and IABP are used to treat various conditions related to heart such as end stage heart failure, refractory angina pectoris, post-cardiopulmonary bypass shock, myocardial infarction, myocarditis, etc. The ventricular assist device is a mechanical pump that supports heart function and blood flow by taking on the workload of the left ventricle, right ventricle or both left and right ventricles helping the heart to pump oxygenated blood to the rest of the body. The indication for VAD use is acute cardiogenic shock (post cardiac surgery, myocarditis and massive myocardial infarction) and chronic heart failure. An artificial heart (TAH) is a mechanical assist device for persons with biventricular heart failure and heart transplant candidate which replaces both native ventricles and all four chambers of heart, thereby eliminating the symptoms of cardiac insufficiency or heart failure. Intra-aortic balloon pump (IABP) is placed in aorta to help the heart to pump more blood by reducing the workload on the heart and improves the function of the left ventricle as this is the chamber that pumps blood into the aorta. IABP is used in conditions such as acute mitral valve regurgitation or severe heart failure, left ventricular failure, unstable angina, etc.

Note: Product cover images may vary from those shown
5 of 6
  • Abbott Laboratories
  • Abiomed, Inc.
  • Balton Sp. Z O.O
  • Berlin Heart GmbH
  • Bivacor, Inc.
  • Calon Cardio-Technology Ltd
  • Cardiobridge GmbH
  • Carmat SA
  • Cleveland Heart, Inc.
  • Corwave SA
  • Evaheart, Inc.
  • Fineheart Sarl
  • Fresenius Medical Care Ag & Co. KGaA (Xenios AG)
  • Getinge Ab (Maquet Holding)
  • GPB Life Science Holdings Llc (Insightra Medical, Inc.)
  • Jarvik Heart, Inc.
  • Medtronic Plc
  • Mitiheart Corporation
  • Oregonheart
  • Procyrion
  • Reliantheart, Inc.
  • Scandinavian Real Heart
  • Senko Medical Instrument Mfg. Co. Ltd
  • Syncardia Systems, LLC
  • Tandem Life (Cardiacsystem, Inc)
  • Teleflex Incorporated
  • Windmill Cardiovascular Systems, Inc. (WCS)
  • Zeon Corporation
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll